SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-019203
Filing Date
2023-11-17
Accepted
2023-11-17 16:55:37
Documents
60
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q gpcr-20230930x10q.htm   iXBRL 10-Q 2851430
2 EX-10.4 gpcr-20230930xex10d4.htm EX-10.4 1218100
3 EX-31.1 gpcr-20230930xex31d1.htm EX-31.1 15756
4 EX-31.2 gpcr-20230930xex31d2.htm EX-31.2 16040
5 EX-32.1 gpcr-20230930xex32d1.htm EX-32.1 9955
6 EX-32.2 gpcr-20230930xex32d2.htm EX-32.2 10242
7 GRAPHIC gpcr-20230930x10q001.jpg GRAPHIC 52936
  Complete submission text file 0001558370-23-019203.txt   10400941

Data Files

Seq Description Document Type Size
8 EX-101.SCH gpcr-20230930.xsd EX-101.SCH 44764
9 EX-101.CAL gpcr-20230930_cal.xml EX-101.CAL 47362
10 EX-101.DEF gpcr-20230930_def.xml EX-101.DEF 202177
11 EX-101.LAB gpcr-20230930_lab.xml EX-101.LAB 451993
12 EX-101.PRE gpcr-20230930_pre.xml EX-101.PRE 338474
54 EXTRACTED XBRL INSTANCE DOCUMENT gpcr-20230930x10q_htm.xml XML 1495121
Mailing Address 611 GATEWAY BLVD SUITE 223 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 223 SOUTH SAN FRANCISCO CA 94080 (628) 229-9277
Structure Therapeutics Inc. (Filer) CIK: 0001888886 (see all company filings)

IRS No.: 981480821 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41608 | Film No.: 231419607
SIC: 2834 Pharmaceutical Preparations